1. Home
  2. VLRS vs ANNX Comparison

VLRS vs ANNX Comparison

Compare VLRS & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Controladora Vuela Compania de Aviacion S.A.B. de C.V.

VLRS

Controladora Vuela Compania de Aviacion S.A.B. de C.V.

HOLD

Current Price

$5.72

Market Cap

675.9M

ML Signal

HOLD

Logo Annexon Inc.

ANNX

Annexon Inc.

HOLD

Current Price

$3.81

Market Cap

726.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VLRS
ANNX
Founded
2005
2011
Country
Mexico
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
675.9M
726.1M
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
VLRS
ANNX
Price
$5.72
$3.81
Analyst Decision
Buy
Buy
Analyst Count
14
10
Target Price
$9.04
★ $15.43
AVG Volume (30 Days)
383.6K
★ 3.4M
Earning Date
10-26-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$20.91
N/A
Revenue Next Year
$7.79
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.59
$2.54
52 Week High
$10.80
$7.18

Technical Indicators

Market Signals
Indicator
VLRS
ANNX
Relative Strength Index (RSI) 28.24 44.05
Support Level N/A $3.71
Resistance Level $7.15 $4.37
Average True Range (ATR) 0.21 0.25
MACD -0.04 0.02
Stochastic Oscillator 14.71 47.12

Price Performance

Historical Comparison
VLRS
ANNX

About VLRS Controladora Vuela Compania de Aviacion S.A.B. de C.V.

Controladora Vuela Compania de Aviacion SAB de CV is a low-cost airline flying to Mexico, the United States, Central, and South America. It uses promotional fares to stimulate demand, and the base fares are priced to compete with long-distance bus fares in Mexico. Revenues from the air transportation of passengers are recognized earlier when the service is provided or when the non-refundable ticket expires on the date of the scheduled travel. Non-passenger revenues include revenues generated from other non-passenger services and cargo services. The Company has two geographic areas identified as domestic (Mexico) and international (United States of America, Central America, and South America).

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.

Share on Social Networks: